For example, BRCA mutations are associated with unfavorable prognosis in breast cancer patients (Brekelmans et al., 2006; Zhong et al., 2015); in addition, a higher MUC16 gene mutation rate indicates a more favorable prognosis in patients with stomach adenocarcinomas (Li et al., 2018). The gene discussed is MUC16; the disease is breast carcinoma.